These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20610599)

  • 1. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
    Wenzlau JM; Juhl K; Yu L; Moua O; Sarkar SA; Gottlieb P; Rewers M; Eisenbarth GS; Jensen J; Davidson HW; Hutton JC
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17040-5. PubMed ID: 17942684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of islet autoantibodies in Thai juvenile-onset type 1 diabetes.
    Trisorus C; Aroonparkmongkol S; Kongmanas HB; Sahakitrungruang T
    Pediatr Int; 2018 Nov; 60(11):1002-1007. PubMed ID: 30151912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.
    Shivaprasad C; Mittal R; Dharmalingam M; Kumar PK
    Indian J Endocrinol Metab; 2014 May; 18(3):345-9. PubMed ID: 24944929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
    Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
    Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, diagnostic utility, and clinical characteristics of ZnT8 antibody in children with type 1 diabetes in Northern Taiwan.
    Su YT; Chou YH; Chiu CF; Huang YC; Lo FS
    Pediatr Neonatol; 2024 Jul; 65(4):395-398. PubMed ID: 38267283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
    Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
    Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc transporter 8 autoantibodies assessment in daily practice.
    Hussein H; Ibrahim F; Sobngwi E; Gautier JF; Boudou P
    Clin Biochem; 2017 Jan; 50(1-2):94-96. PubMed ID: 27363941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
    Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
    Clin Immunol; 2011 Feb; 138(2):146-53. PubMed ID: 21067978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of zinc transporter 8 autoantibody in the diagnostic classification of acute-onset diabetics].
    YANG L; LUO SM; HUANG G; PENG J; YAN X; WENZLAU J; DAVIDSON HW; HUTTON JC; ZHOU ZG
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(36):2536-40. PubMed ID: 21092458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies.
    Bost C; Jordan T; Magali D; Françoise F; Nicole F
    Clin Chim Acta; 2020 Dec; 511():1-6. PubMed ID: 32946793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.
    Petruzelkova L; Ananieva-Jordanova R; Vcelakova J; Vesely Z; Stechova K; Lebl J; Dusatkova P; Sumnik Z; Coles R; Powell M; Furmaniak J; Rees Smith B; Kolouskova S
    Diabet Med; 2014 Feb; 31(2):165-71. PubMed ID: 23952619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
    Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.